The P-scores, which rank treatments based on their effectiveness with higher scores indicating more favorable outcomes, were highest for Resmetirom (0.42), followed by GLP-1 (0.38), and FGF21 (0.24)
"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026
Official guidance from UK health authorities The National Institute for Health and Care Excellence (NICE) recommends GLP-1 drugs for patients with type 2 diabetes or with a very high BMI 12
But I do think there are so many important and well described neuronal populations that have the GLP-1 receptor and which are accessible from the periphery
Some research teams are exploring microneedle (MN) or microarray patch (MAP) delivery systems designed to bypass the outer skin barrier by creating microscopic channels
This should initially occur at one month and subsequently every four months